Delivery Order SPE2DB20D1004-SPE2DB25FNHKR
Award Date 6/2/25
Potential Completion Date 6/3/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,452.88 by the Defense Logistics Agency (DLA) for MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract is competitively awarded with no set-aside designation and operates under a firm fixed price structure, with an ultimate completion date of August 4, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- This delivery order, valued at $14,528.80 and awarded September 3, 2025, represents a competitive procurement by the Defense Logistics Agency (DLA) for MENQUADFI vials (0.5mL) from AmerisourceBergen Drug Corp, the primary pharmaceutical distributor for federal military and healthcare systems. The award is non-set-aside and utilizes firm fixed-price pricing, with completion scheduled for September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for pharmaceutical supplies, specifically MENQUADFI vial 0.5ML, with a ceiling value of $1,452.88. This delivery order utilizes a firm fixed price contract type and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency for the supply of Menquadfi vial 0.5ML pharmaceutical product. This competitively awarded, non-set-aside contract has a ceiling value of $2,905.80 with firm fixed pricing and an ultimate completion date of August 12, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $5,085.08 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $1,452.88. This firm fixed price delivery order is not set-aside and is scheduled for completion by August 14, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.88 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5mL on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed price delivery order, which is not set-aside, will be performed in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI vials (0.5mL) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without set-aside designation, reflects a competitively awarded transaction under the company's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML pharmaceutical products with a ceiling value of $12,636.92 under a firm fixed price contract type. The award was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for MENQUADFI VIAL 0.5ML, a pharmaceutical product. This firm fixed price contract, awarded on September 2, 2025, with a completion date of September 3, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was not designated as a set-aside contract and will be performed at the contractor's location in...